Clinical Trials Browser

Phase 2 × Gemtuzumab × Lymphoid × Clear all

NCT00798213 2015-02-04

SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED)

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma